| 摘要 |
The present invention relates to use of complement C9 protein or gene encoding the same as a diagnostic marker for cancer, a diagnostic composition for cancer comprising an agent that measures the expression level of complement C9 mRNA or protein encoded thereby, a diagnostic kit for cancer comprising the diagnostic composition for cancer, a method for diagnosing cancer using the complement C9 as a diagnostic marker, and a method for screening a therapeutic agent for cancer using the complement C9 as a diagnostic marker. |
